[HTML][HTML] MMP9: a tough target for targeted therapy for cancer

K Augoff, A Hryniewicz-Jankowska, R Tabola, K Stach - Cancers, 2022 - mdpi.com
Simple Summary MMP9, due to its proteolytic activity, plays a key role in tumorigenesis by
regulating migration, epithelial-to-mesenchymal transition and survival of cancer cells …

[HTML][HTML] The rebirth of matrix metalloproteinase inhibitors: moving beyond the dogma

GB Fields - Cells, 2019 - mdpi.com
The pursuit of matrix metalloproteinase (MMP) inhibitors began in earnest over three
decades ago. Initial clinical trials were disappointing, resulting in a negative view of MMPs …

Recent advances in understanding the roles of matrix metalloproteinases in tumour invasion and metastasis

GA Conlon, GI Murray - The Journal of pathology, 2019 - Wiley Online Library
This review aims to provide an overview of recent developments regarding the roles of
MMPs in tumour invasion and metastasis. Much of the mortality burden belonging to cancer …

Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies

S Das, SA Amin, T Jha - European journal of medicinal chemistry, 2021 - Elsevier
Abstract Matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) are
collectively known as gelatinases whereas MMP-2 is gelatinase-A and MMP-9 is termed as …

[HTML][HTML] Mechanisms of action of novel drugs targeting angiogenesis-promoting matrix metalloproteinases

GB Fields - Frontiers in immunology, 2019 - frontiersin.org
Angiogenesis is facilitated by the proteolytic activities of members of the matrix
metalloproteinase (MMP) family. More specifically, MMP-9 and MT1-MMP directly regulate …

Matrix metalloproteinases as new targets in Alzheimer's disease: Opportunities and challenges

P Zipfel, C Rochais, K Baranger, S Rivera… - Journal of Medicinal …, 2020 - ACS Publications
Although matrix metalloproteinases (MMPs) are implicated in the regulation of numerous
physiological processes, evidence of their pathological roles have also been obtained in the …

Recent progress in the strategic incorporation of fluorine into medicinally active compounds

K Haranahalli, T Honda, I Ojima - Journal of fluorine chemistry, 2019 - Elsevier
This account exemplifies our recent progress on the strategic incorporation of fluorine and
organofluorine groups to (i) taxoid anticancer agents,(ii) acylhydrazone-based antifungal …

[HTML][HTML] Ginsenoside Rg3 Alleviates ox-LDL Induced Endothelial Dysfunction and Prevents Atherosclerosis in ApoE−/− Mice by Regulating PPARγ/FAK Signaling …

J Geng, W Fu, X Yu, Z Lu, Y Liu, M Sun, P Yu… - Frontiers in …, 2020 - frontiersin.org
The initiation of atherosclerosis (AS) induced by dyslipidemia is accompanied by endothelial
dysfunction, including decreased healing ability and increased recruitment of monocytes …

[HTML][HTML] Bioguided fractionation of local plants against matrix metalloproteinase9 and its cytotoxicity against breast cancer cell models: In silico and in vitro study

M Hariono, R Rollando, J Karamoy, P Hariyono… - Molecules, 2020 - mdpi.com
Matrix metalloproteinase9 (MMP9) is known to be highly expressed during metastatic cancer
where most known potential inhibitors failed in the clinical trials. This study aims to select …

[HTML][HTML] Validating cell surface proteases as drug targets for cancer therapy: what do we know, and where do we go?

E Verhulst, D Garnier, I De Meester, B Bauvois - Cancers, 2022 - mdpi.com
Simple Summary Cell surface proteases (so-called ectoproteases) are associated with
cancer, and their targeting may confer valuable options for the improvement of cancer …